Lisinopril hctz 20 25 mg
Pro Research Analysisby 
Searched over 200M research papers
Efficacy and Safety of Lisinopril-Hydrochlorothiazide 20/25 mg in Hypertension Management
Introduction to Lisinopril-Hydrochlorothiazide Combination
Lisinopril, an angiotensin-converting enzyme inhibitor (ACEI), and hydrochlorothiazide (HCTZ), a thiazide diuretic, are commonly combined to treat hypertension. The combination of lisinopril 20 mg and HCTZ 25 mg has been shown to be effective in controlling blood pressure (BP) in patients with mild to moderate essential hypertension .
Blood Pressure Reduction Efficacy
Short-term and Long-term Efficacy
Studies have demonstrated that the combination of lisinopril and HCTZ provides superior BP control compared to monotherapy with either drug alone. In a controlled multicenter study, patients treated with lisinopril 20 mg and HCTZ 25 mg experienced significant reductions in both systolic and diastolic BP over 12 weeks, with further improvements observed over a 24-week period. This combination therapy was more effective than either lisinopril or HCTZ alone in reducing BP .
Comparison with Other Antihypertensive Agents
When compared to other antihypertensive agents such as atenolol and captopril, the lisinopril-HCTZ combination showed superior efficacy. For instance, a study comparing lisinopril-HCTZ with captopril-HCTZ found that the former produced a greater reduction in diastolic BP and had a higher percentage of patients achieving target BP levels . Additionally, the combination was more effective in maintaining 24-hour BP control compared to captopril-HCTZ.
Safety and Tolerability
Adverse Effects
The combination of lisinopril and HCTZ is generally well-tolerated. Common side effects include cough, which is more frequently associated with lisinopril, and elevated uric acid levels, which are more common with HCTZ . Serious adverse effects are rare, occurring in less than 3% of patients during both short-term and long-term therapy.
Comparison with Other Combinations
In comparison to other antihypertensive combinations, such as telmisartan-HCTZ, the lisinopril-HCTZ combination has a comparable efficacy but a different side effect profile. Telmisartan-HCTZ was associated with fewer incidences of cough and angioedema compared to lisinopril-HCTZ, making it a potentially better-tolerated option for some patients.
Conclusion
The combination of lisinopril 20 mg and hydrochlorothiazide 25 mg is an effective and well-tolerated option for the treatment of mild to moderate hypertension. It offers superior BP control compared to monotherapy and other antihypertensive combinations, with a manageable side effect profile. This makes it a valuable option in the management of hypertension, particularly for patients who require combination therapy to achieve optimal BP control.
Sources and full results
Most relevant research papers on this topic